121 related articles for article (PubMed ID: 2141511)
61. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
[TBL] [Abstract][Full Text] [Related]
62. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
63. Clinicopathological Characteristics and Overall 5-Year Survival of Colorectal Cancer: A Retrospective Study.
Almuhanna R; Al-Thoubaity F; Almalki K; Algarni N; Hamad R; Makhtoum T
Med Sci (Basel); 2022 Aug; 10(3):. PubMed ID: 35997334
[TBL] [Abstract][Full Text] [Related]
64. The impact of homologous packed red blood cell transfusion on patients' survival after radical surgical treatment of colorectal cancer.
Lobaziewicz W; Kołodziejski L
Acta Chir Belg; 2008; 108(5):524-31. PubMed ID: 19051460
[TBL] [Abstract][Full Text] [Related]
65. Comparative evaluation of investigations for colorectal carcinoma in symptomatic patients.
Kalra L; Hamlyn AN
Postgrad Med J; 1988 Sep; 64(755):666-8. PubMed ID: 3251216
[TBL] [Abstract][Full Text] [Related]
66. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer.
Ng T; Ryder BA; Chern H; Sellke FW; Machan JT; Harrington DT; Cioffi WG
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):815-9. PubMed ID: 22325327
[TBL] [Abstract][Full Text] [Related]
67. Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.
Di Gregorio C; Benatti P; Losi L; Roncucci L; Rossi G; Ponti G; Marino M; Pedroni M; Scarselli A; Roncari B; Ponz de Leon M
Int J Colorectal Dis; 2005 Mar; 20(2):147-54. PubMed ID: 15592853
[TBL] [Abstract][Full Text] [Related]
68. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients.
Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RCG; Winslow ER; Maithel SK
HPB (Oxford); 2016 Feb; 18(2):192-199. PubMed ID: 26902139
[TBL] [Abstract][Full Text] [Related]
69. Blood transfusions in laryngeal cancer: effect on prognosis.
Leon X; Quer M; Luz Maestre M; Burgues J; Muniz E; Madoz P
Head Neck; 1996; 18(3):218-24. PubMed ID: 8860761
[TBL] [Abstract][Full Text] [Related]
70. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
71. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
72. [Effect of the transfusion of blood and hemoderivatives on the prognosis of colorectal cancer].
Hermanek P; Guggenmoos-Holzmann I; Schricker KT; Resch T; Freudenberger K; Neidhardt P; Gall FP
Langenbecks Arch Chir; 1989; 374(2):118-24. PubMed ID: 2704281
[TBL] [Abstract][Full Text] [Related]
73. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
Cai SR; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
[TBL] [Abstract][Full Text] [Related]
74. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
75. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
Stephens RW; Nielsen HJ; Christensen IJ; Thorlacius-Ussing O; Sørensen S; Danø K; Brünner N
J Natl Cancer Inst; 1999 May; 91(10):869-74. PubMed ID: 10340907
[TBL] [Abstract][Full Text] [Related]
76. [Prognostic factors in colorectal neoplasm. Multivariate analysis in 224 patients].
Bannura G; Cumsille MA; Contreras J; Melo C; Barrera A; Reinero M; Pardo L
Rev Med Chil; 2001 Mar; 129(3):237-46. PubMed ID: 11372289
[TBL] [Abstract][Full Text] [Related]
77. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
78. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
79. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
80. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
